| Recruiting | Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts NCT07534865 | First Hospital of China Medical University | N/A |
| Not Yet Recruiting | Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulga NCT07457918 | Verrica Pharmaceuticals Inc. | Phase 3 |
| Not Yet Recruiting | the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts. NCT07396714 | Assiut University | EARLY_Phase 1 |
| Recruiting | Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) NCT07246590 | Verrica Pharmaceuticals Inc. | Phase 3 |
| Not Yet Recruiting | Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparativ NCT06973473 | Assiut University | — |
| Recruiting | Multicenter Real-World Study of Hyperthermia in Warts of Special Population NCT06827938 | First Hospital of China Medical University | N/A |
| Recruiting | Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts NCT05625633 | Western Institute for Veterans Research | Phase 2 / Phase 3 |
| Completed | Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar War NCT06214559 | Swiss Footcare Laboratories - Poderm Professional | N/A |
| Completed | Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic NCT07329907 | Benha University | Phase 2 |
| Completed | Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts NCT05781841 | Sohag University | — |
| Completed | Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts NCT05799157 | Veradermics, Inc. | Phase 2 |
| Recruiting | Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Wa NCT06812065 | First Hospital of China Medical University | N/A |
| Unknown | Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts NCT05616078 | The 306 Hospital of People's Liberation Army | N/A |
| Unknown | Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts NCT05617950 | The 306 Hospital of People's Liberation Army | N/A |
| Completed | ERAP1,2 in Recalcitrant Warts NCT06833164 | Benha University | — |
| Unknown | Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases NCT05488860 | Xiangya Hospital of Central South University | N/A |
| Active Not Recruiting | Microwave Treatment of Common and Plantar Warts NCT05371834 | Blackwell Device Consulting | N/A |
| Unknown | Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts NCT05300009 | Assiut University | N/A |
| Completed | Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts NCT05712811 | Combined Military Hospital Abbottabad | N/A |
| Completed | Intralesional HPV Vaccine for Condylomata NCT05087849 | University of California, San Francisco | Phase 1 / Phase 2 |
| Recruiting | Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts NCT05291845 | Zagazig University | Phase 2 |
| Completed | CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts NCT04738734 | Pulse Biosciences, Inc. | N/A |
| Completed | Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment NCT04781244 | Mahidol University | N/A |
| Completed | Intralesional Vitamin D Injection for Treatment of Common Warts NCT04278573 | Stephen P. Merry | Phase 2 |
| Unknown | Topical 2% Povidone-Iodine Gel in Verruca Vulgaris NCT04253912 | Veloce BioPharma LLC | Phase 2 |
| Completed | Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plant NCT06309420 | Oystershell NV | N/A |
| Completed | CellFX System for the Treatment of Cutaneous Non-Genital Warts NCT04554394 | Pulse Biosciences, Inc. | N/A |
| Completed | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts NCT03981822 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Unknown | The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Pal NCT03477448 | Assiut University | Phase 4 |
| Completed | Cantharidin and Occlusion in Verruca Epithelium NCT03487549 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Unknown | Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts NCT03158168 | Assiut University | Phase 3 |
| Completed | Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Wa NCT04399577 | Zagazig University | Phase 2 |
| Completed | Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo NCT02902822 | Centro Studi Gised | N/A |
| Withdrawn | Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. NCT02567149 | University of Minnesota | Phase 2 |
| Unknown | Using a Cold Atmospheric Plasma Device to Treat Skin Disorders NCT02759900 | The Skin Center Dermatology Group | N/A |
| Completed | Clinical Study : Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment NCT03129373 | Oystershell NV | N/A |
| Completed | Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) NCT02393417 | Nielsen BioSciences, Inc. | Phase 2 |
| Completed | Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome NCT02231879 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | Efficacy of Laser Versus Cryotherapy in the Treatment of Warts NCT01808443 | The 306 Hospital of People's Liberation Army | N/A |
| Completed | Candin Safety & Efficacy Study for the Treatment of Warts NCT01757392 | Nielsen BioSciences, Inc. | Phase 2 |
| Unknown | 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts NCT01712295 | Grossman, Michael, D.P.M. | Phase 4 |
| Completed | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy NCT01101750 | Medstar Health Research Institute | Phase 4 |
| Recruiting | A Phase I Study of Mozobil in the Treatment of Patients With WHIMS NCT00967785 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands NCT00973856 | Cleveland Clinic Akron General | N/A |
| Recruiting | Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia NCT00867269 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Anogenital Wart Burden and Cost of Illnesses NCT00749294 | Mahidol University | — |
| Withdrawn | The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of C NCT00546611 | Peplin | Phase 1 |
| Completed | Study With Candida Antigen for Treatment of Warts NCT00569231 | University of Arkansas | Phase 1 |
| Unknown | Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial NCT00254280 | Bispebjerg Hospital | N/A |
| Completed | An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects NCT00116662 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects NCT00116675 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Study With a Topical Gel to Treat Common Warts in Adults NCT00117871 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Study With a Topical Gel to Treat Common Warts in Adults NCT00117923 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults NCT00115141 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults NCT00114920 | Graceway Pharmaceuticals, LLC | Phase 2 |
| Completed | Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-me NCT00472459 | Galderma R&D | Phase 3 |
| Completed | Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients NCT00761371 | MEDA Pharma GmbH & Co. KG | Phase 4 |
| Unknown | Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris NCT00155584 | National Taiwan University Hospital | — |